The gene on chromosome 10 at band p12 (AFlO), involved in the t(10;ll) translocation in acute myeloid leukemia, has been identified and shown to contain conserved zinc finger and leucine zipper domains. These regions are highly homologous to the equivalent regions on AF17, the gene involved in the t(11;17) translocations. A series of adult, childhood, and infant leukemias with either simple or complex versions of the t(10;ll) has been examined by Southern analysis and shown to involve rearrangement to the HRX locus. Reverse transcriptase-polymerase chain reaction from either bone HE t( 10; 11) TRANSLOCATION has been previously re~orted,"~ particularly in association with acute myeloid leukemia (Ah4L; French-American-British [FA331 subgroup M5). This abnormality belongs to a group of chromosome translocations affecting chromosome 1 1 at band q23 and has been shown to involve the HRXMLL An unusual feature of this group of translocations is that a wide variety of partner chromosome regions have been reported to be rearranged with 11q23.6 Although most translocations affecting llq23 result in two reciprocal junctions, current cytogenetic and molecular evidence suggests that it is the der(l1) chromosome that is critical for the development of such leukemias.' The clustering of breakpoints within the HRX locus predicts that the resultant chimeric protein expressed from the der(l1) chromosome has the zinc finger region and downstream elements of HRX replaced by the corresponding region of the protein encoded by the gene at the breakpoint on the other chromosome. A total of 9 such partner genes has now been identified and, because the majority are unrelated to each other, they can be predicted to supply diverse COOH-terminal elements to create the chimeric HRX protein in each translocation.'"' Because of this diversity, it has not yet been possible to discern any consistent feature in the sequences added to the HRX gene; thus, the role of the partner genes in these events has remained obscure. Recently, the partner genes for the t( 11; 17) and the t(l0; 1 l) translocations have been ~l o n e d . '~, '~ A F l O and AF17 are related to each other through the presence of conserved zinc finger and leucine zipper structures, features that have not been found so far in any other partner genes. We report that the t(l0; 11) translocation consistently results in the expression of a chimeric H W A F 1 0 mRNA encoding an intact leucine zipper dimerization motif.
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MATERIALS AND METHODS
RNA preparation.
Cryopreserved peripheral blood cells for patients A, B, and C were thawed and incubated in 10% fetal calf serum to neutralize the dimethylsulfoxide. Total RNA was extracted using the RNAzol-B method (Biogenesis, Bournemouth, UK) and stored frozen in water at -20°C. For patients D, E, F, and G, total RNA was isolated via the guanidinium isothiocyanate (GTC) method from cryopreserved blood or bone marrow cells. Cloning. Fresh PCR products were cloned into plasmid via the TA cloning kit (Invitrogen, San Diego, CA). PCR reactions were performed using the original primers used in the first reactions, and clones with appropriately sized inserts were grown overnight and used to prepare "miniprep" DNA by the alkaline lysis method.
Sequence analysis. One microgram of plasmid DNA was Taq cycle sequenced using the Applied Biosystems PRISM Ready Reaction Dye-Deoxy terminator sequencing kit (Applied Biosystems, Warrington, UK), and the products were extracted with phenolkhloroform. Samples were run on an AB1 373A DNA sequencer (Applied Biosystems) and the results were analyzed using DNAstar software (DNAStar, Madison, WI).
Southern analysis. High molecular weight DNA was extracted from the patients' leukemic cells and digested with various restric- The oligonucleotide AFlOpmr41 was used in combination with AFlOpmrl8 as a positive control in the RT-PCR reactions. (Table 21 . The HRX exon 5 primer (Table 11 was used in combination AFlO pmrl8 (lanes A and C) and with AFlO pmr29 (lanes D, E, F, and GI.
shown in Fig 1 b. To confirm the origin of all products, they were either subjected to direct sequencing or cloned into plasmid before sequence analysis. In each example it was possible to identify the precise fusion points between HRX and AFIO; these results are presented in Table 2 . The material from patients A and B were used in the original cloning of AFIO; therefore, their fusion points were already known." The base positions given for AFlO correspond to the GEN-BANK entry for AFlO (accession no. U13948). A second minor product was derived from patient D, was shown to consist of a fusion between HRX exon 6 and AFIO, and was interpreted as being due to alternative splicing that would 11 University College Hospital (London, UK).
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46,XY,t(11;10;9)(q23:pl2;q33),add~l2l(pl3~ remove HRX exon 7. The five fusion points found on AFlO are indicated in relation to the conserved zinc finger and leucine zipper regions (Fig 2) and all resulted in in-frame fusions between HRX and AFIO.
DISCUSSION
All 1 lq23 translocations so far investigated result in inframe fusions between the 5' HRX and 3' elements of the involved partner gene. The molecular cloning of the partner genes has not identified any consistent features in the 3' elements donated to HRX. Indeed, the partner genes seem to constitute a diverse group with only partial homology between certain members. The genes AF9 and ENL are related to each other through 5' and 3' regions of homology,'" and AFlO and AF17 are related through the presence of zinc finger and leucine zipper structures.I4 The remainder (AF4, AF6, AFI-p, ELL, and AFlq) are unrelated at the sequence are rich in serines and prolines, suggesting a role as transcriptional activators. The gene previously named AFlp is the human homolog of the murine eps I5 (epidermal growth factor [EGF] receptor pathway substrate 15). epsl5 encodes a cytoplasmic protein that is a target for the tyrosine kinase activity of the EGF receptor, epsl5, like the AF6 protein, exhibits similarities with the rod-like region of various myosin chains, structures known to be involved in protein-protein interactions. It was thus suggested that the partner protein contributes a dimerization domain. To understand the role of the partner gene in these events, it will be necessary to determine if any elements are consistently translocated to HRX in a range of translocations.
Our data show that a consistent feature of the t( 10; 11)
translocation is the creation of HRWAFIO chimeric protein containing the AFlO leucine zipper motif. No breakpoints 3' of the leucine zipper were found. The AF17 gene also encodes a leucine zipper region 77% identical to that of AFIO; the limited data available for t(l1; 17) translocations (2 patients) suggest that a similar structure of chimeric HRW AF17 protein would result. These results indicate an important role for the leucine zipper motif in the chimeric protein. Sequence comparison of AFlO with AF17 and with a related C elegans gene CEZF indicates considerable divergence outside the zinc finger and leucine zipper region^.'^ Thus, there has been selective pressure to maintain the leucine zipper, suggesting that it has an important functional role. There is a precedent for the involvement of a leucine zipper motif in chimeric proteins. The t(17; 19)(q22;p13) translocation has been shown to result in chimeric transcripts that contain sequences from the E2A basic helix-loop-helix ~eve~~8.11.12,1f~-Ix Several carry nuclear localisation signals and gene fused to the leucine zipper sequence of the HLF This translocation, which occurs in pre-B-cell acute lymphocytic leukemia (ALL), particularly with disseminated intravascular coagulation, is related to the more frequent t( 1 ; 19)(q23;p13) that also occurs in pre-B ALL. However, in this case, the translocation fuses the homeobox domain of the PBX1 gene on chromosome I to the E2A basic helix loop-helix gene on chromosome 19. Thus, as with the 1 lq23 translocations, the E2A family of translocations includes events that involve the transfer of a leucine zipper motif.
The five infant and childhood leukemias studied had only two fusion points on AFIO, whereas the three adult leukemias appeared to have more widely scattered fusion points on AFIO. More leukemias will have to be examined before any significance can be attached to the distribution of AFlO fusion points. In patient A, the translocation joined exon 5 HRX sequence to AFlO sequence. This was the first observation of such breakpoint position on HRX for any of the 1 lq23 abnormalities. This study confirms that it is also unusual in the t( 10; 11) translocation.
The cytogenetic evidence suggests that there may be heterogeneity in the breakpoints on lop with lop1 1 IOp12,4 10~13,' IOp14,2' and 1 0 p 1 5~2 all of which are implicated in rearrangements with 1 lq23. In addition, a complex insertion ins( IO; 1 1) has been noted involving 10ps.23.24 and is observed in four of our acute leukaemias. Despite the cytogenetic complexity of some of these rearrangements, we have been able to show that consistent fusions between HRX and AFlO result. RT-PCR can therefore be used as a valuable diagnostic test in cases in which the t(10; 11) translocation is suspected. The full elucidation of these complex rearrangements will require further investigation using the DNA probes generated in this study.
